Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather A Wakelee

Showing results (1-10 of 255) with videos related to

Pageof 26
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Commentary: highlights in NSCLC from the 15th World Conference on Lung CancerHeather A Wakelee
Clinical Advances in Hematology & Oncology : H&O|May 24, 2014
Commentary: highlights in NSCLC from the 15th World Conference on Lung CancerHeather A Wakelee
Journal of Thoracic Disease|September 22, 2017
The J-ALEX trial-is frontline alectinib a new standard of care?Jeffrey Zweig, Heather A Wakelee
Translational Lung Cancer Research|March 26, 2015
Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)Ying Liang, Heather A Wakelee
Cancer Treatment and Research|August 19, 2016
Resistance to TherapyGabriel Rivera, Heather A Wakelee
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2009
Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancerYelena Krupitskaya, Heather A Wakelee
Clinical Lung Cancer|September 15, 2005
Targeting angiogenesis with vascular endothelial growth factor receptor small-molecule inhibitors: novel agents with potential in lung cancerHeather A Wakelee, Joan H Schiller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Elusive Target of Angiogenesis in Small-Cell Lung CancerJoel W Neal, Heather A Wakelee
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 17, 2009
Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapyJerry Y Hsu, Heather A Wakelee
Expert Opinion on Biological Therapy|December 4, 2012
Aflibercept in lung cancerJoel W Neal, Heather A Wakelee
Pageof 26

Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Commentary: highlights in NSCLC from the 15th World Conference on Lung CancerHeather A Wakelee
Clinical Advances in Hematology & Oncology : H&O|May 24, 2014
Commentary: highlights in NSCLC from the 15th World Conference on Lung CancerHeather A Wakelee
Journal of Thoracic Disease|September 22, 2017
The J-ALEX trial-is frontline alectinib a new standard of care?Jeffrey Zweig, Heather A Wakelee
Translational Lung Cancer Research|March 26, 2015
Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)Ying Liang, Heather A Wakelee
Cancer Treatment and Research|August 19, 2016
Resistance to TherapyGabriel Rivera, Heather A Wakelee
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2009
Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancerYelena Krupitskaya, Heather A Wakelee
Clinical Lung Cancer|September 15, 2005
Targeting angiogenesis with vascular endothelial growth factor receptor small-molecule inhibitors: novel agents with potential in lung cancerHeather A Wakelee, Joan H Schiller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Elusive Target of Angiogenesis in Small-Cell Lung CancerJoel W Neal, Heather A Wakelee
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 17, 2009
Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapyJerry Y Hsu, Heather A Wakelee
Expert Opinion on Biological Therapy|December 4, 2012
Aflibercept in lung cancerJoel W Neal, Heather A Wakelee
Pageof 26